Results 41 to 50 of about 8,067 (167)

Differences in engagement and outcomes in a postpartum hypertension monitoring program by infant NICU admission

open access: yesPregnancy, Volume 2, Issue 3, May 2026.
Abstract Introduction Remote postpartum self‐measured blood pressure (SMBP) monitoring programs improve rates of recommended BP ascertainment among individuals with hypertensive disorders of pregnancy (HDP) overall. Healthcare utilization patterns differ among individuals whose infants are admitted to the neonatal intensive care unit (NICU) and those ...
Mary Marchese   +12 more
wiley   +1 more source

Reversible Neurological Manifestations Preceding Biochemical Deterioration in Postpartum HELLP Syndrome—A Case Report and Literature Review

open access: yesThe Journal of Clinical Hypertension, Volume 28, Issue 5, May 2026.
ABSTRACT Posterior reversible encephalopathy syndrome (PRES) is a rare but severe neurological complication associated with hypertensive disorders of pregnancy and HELLP syndrome. We report a postpartum case in which neurological manifestations preceded the full biochemical expression of HELLP syndrome. A 22‐year‐old primigravida was admitted at 36 + 0
Dario Colacurci   +19 more
wiley   +1 more source

Comparison between Effects of Intravenous Labetalol and Hydralazine on Control of Hypertension and Maternal and Neonatal Outcomes in Severe Preeclamptic Patients: A Randomized Clinical Trial

open access: yes, 2013
Background and Objectives: Severe preeclampsia and eclampsia are responsible for 25% of maternal mortality, especially in developing countries. Considering the importance of this complication, the present study aimed to compare between effects of ...
Oghbaee N.   +3 more
core  

Lipid Emulsions Inhibit Labetalol-Induced Vasodilation in the Isolated Rat Aorta

open access: yes
Lipid emulsions are used as adjuvant drugs to alleviate intractable cardiovascular collapse induced by drug toxicity. We aimed to examine the effect of lipid emulsions on labetalol-induced vasodilation and the underlying mechanism in the isolated rat ...
Kyeong-Eon Park   +9 more
core   +1 more source

Evaluation of efficacy and safety of intravenous hydralazine vs. labetalol in pregnancy related hypertension.

open access: yes, 2021
: Objective: The aim of this study was to evaluate the efficacy and safety of intravenous hydralazine in comparison with labetalol in pregnancy related hypertension.
Zain ul abideen   +2 more
core   +1 more source

Uptake and Costs of the 60‐Day Dispensing Policy for Antihypertensive Medicines in Australia: A Mixed Methods Study

open access: yesMedical Journal of Australia, Volume 224, Issue 4, April 2026.
ABSTRACT Objectives To evaluate the uptake of a new 60‐day dispensing policy for antihypertensive medicines and estimated cost savings compared with conventional 30‐day dispensing; and to explore general practitioner and pharmacist perspectives on the new policy.
Tian Wang   +9 more
wiley   +1 more source

Effect of labetalol on cerebral blood flow, oxygen metabolism and autoregulation in healthy humans

open access: yes, 1995
We have studied the effects of labetalol on cerebral blood flow (CBF) and cerebral oxygen metabolism (CMRO2) in eight healthy volunteers. CBF was measured by single photon emission computerized tomography before and during infusion of labetalol.
Paulson, O B   +3 more
core   +1 more source

Influencia del uso materno de labetalol en el mecanismo neurogénico de autorregulación cerebral evaluado mediante NIRS

open access: yes, 2014
Labetalol is a drug used in the treatment of hypertensive disorders of pregnancy (HDP). In a previous study we investigated the influence of the maternal use of labetalol on the cerebral autoregulation (CA) mechanism of neonates.
Lemmers, Petra   +12 more
core   +1 more source

A prediction model for the response to oral labetalol for the treatment of antenatal hypertension

open access: yes, 2016
This prospective observational study aimed to identify at presentation the maternal hemodynamic and demographic variables associated with a therapeutic response to oral labetalol and to use these variables to develop a prediction model to anticipate the ...
Paraschiv, D.   +5 more
core   +1 more source

Beneficial effect of labetalol in hypertensive patients with angina pectoris

open access: yes, 2017
Labetalol (Trandate; Alien &Hanbury) was administered to 17 hypertensive patients with angina pectoris, which had persisted despite blood pressure control on treatment including B-blocking agents.
White, D. A., Lubbe, W.F.
core  

Home - About - Disclaimer - Privacy